Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women

Journal of the American Geriatrics Society

Volumn 46, Issue 3, 1998, Pages 263-273

  Abbasi, Adil ^a,c   Duthie Jr , Edmund H ^a   Sheldahl, Lois ^b   Wilson, Charles ^b   Sasse, Edward ^b   Rudman, Inge ^a   Mattson, Dale E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FITNESS; HORMONE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MALE; NORMAL HUMAN; SEX DIFFERENCE;

EID: 0031884528     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01036.x     Document Type: Article

References (55)

1. Vandewiele RL, MacDonald PC, Gurpide E, Lieberman S. Studies on the secretion and interconversion of the androgens. Recent Prog Horm Res 1963;19:275-310.
2. Smith MR, Rudd BT, Shirley A et al. A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulphate in normal and pathological sera. Clin Chim Acta 1975;65:5-13.
3. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
4. Orentreich N, Brind JL, Vogelman JH et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992;75:1002-1004.
5. Birkenhager-Gillesse EG, Derksen J, Lagaay AM. Dehydroepiandrosterone sulfate (DHEAS) in the oldest old, aged 85 and over. Ann NY Acad Sci 1994;719:543-552.
6. Ebeling P, Koivista VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479-1481.
7. Barret-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;315:1519-1524.
8. Newcomer LM, Manson JE, Barbieri RL et al. Dehydroepiandrosterone sulfate and the risk of myocoardial infarction in US male physicians: A prospective study. Am J Epidemiol 1994;140:870-875.
9. Coleman MP, Key TJ, Wang DY et al. A prospective study of obesity, lipids, apolipoproteins, and ischemic heart disease in women. Atherosclerosis 1992;92:177-185.
10. Cleary MP. The antiobesity EFFECT of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 1991;196:8-16.
11. Tagliaferro AR, Davis JR, Truchon S, Van Hamont N. Effects of dehydroepiandrosterone acetate on metabolism, body weight, and composition of male and female rats. J Nutr 1986;116:1977-1983.
12. Coleman DL, Leiter EH, Applezweig N. Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57bL/DsJ-db/db). Endocrinology 1984;115:239-243.
13. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimai injury. J Clin Invest 1988;Aug 82:712-720.
14. Schwartz AG. Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 1979;39:1129-1132.
15. Nyce JW, Magee PN, Hard GC, Schwartz AG. Inhibition of 1,2 dimethylhydrazine induced colon tumotigenesis in BALB/c mice by dehydroepiandrosterone. Carcinogenesis (Lond.) 1984:5:57-62.
16. Lucas JA, Ahmed SA, Casey ML, MacDonald PC. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroepiandrosterone. J Clin Invest 1985;75:2091-2093.
17. Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal man. J Clin Endocrinol Metab 1988;66:57-61.
18. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-1367.
19. Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990;71:696-704.
20. Field AE, Colditz GA, Willett WC et al. The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79:1310-1316.
21. Barrett-Connor E, Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and non-insulin dependent diabetes in postmenopausal women. The Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81:59-64.
22. Khaw KT, Tazuke S, Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318:1705-1709.
23. Salvini S, Stampfer MJ, Barbiere RL, Hennekens CH. Effects of age, smoking and vitamins on plasma DHEAS levels: A cross-sectional study in men. J Clin Endocrinol Metab 1992;74:139-143.
24. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 1987;47:398-401.
25. Sallis JF, Haskell WL, Wood PD et al. Physical activity assessment methodology in the five city project. Am J Epidemiol 1985;121:91-106.
26. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign IL: Human Kinetics Books, 1988.
27. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-1112.
28. Sheldahl LM, Tristani FE, Clifford PS et al. Effect of head out water immersion on cardiorespiratory response to dynamic exercise. J Am Coll Cardiol 1987;10:1254-1258.
29. Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid ethanol-extracted serum. J Clin Endocrinol Metab 1980;51:781-788.
30. Coyotupa J, Parlow F, Abraham GE. Simultaneous radioimmunoassay of plasma testosterone and dihydrotestosterone. Anal Lett 1972;5:329-340.
31. Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sexhormone-binding globulin. Clin Chem 1987;33:1372-1375.
32. Keizer H, Janssen GM, Menheere P, Kranenburg G. Changes in basal plasma testosterone, cortisol and dehydroepiandrosterone sulfate in previously untrained males and females preparing for a marathon. Int J Sports Med 1989;10(suppl 3):S139-145.
33. Rosenfeld RS, Hellman L, Roffworg H et al. Dehydroepiandrosterone is secreted episodically and synchronously with Cortisol by normal man. J Clin Endocrinol Metab 1971;33:87-92.
34. Nieschlag E, Coriaux DL, Ruder HJ et al. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol 1973;57:123-134.
35. Dorgan JF, Reichman ME, Judd JT et al. The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 1994;5:53-60.
36. Arquitt AB, Stoecker BJ, Hermann JS, Winterfeldt EA. Dehydroepiandrosterone sulfate, cholesterol, hemoglobin, and anthropometric measures related to growth in male adolescents. J Am Diet Assoc 1991;91:575-579.
37. DePergola G, Cospite MR, Giagulli VA et al. Insulin-like growth factor-1 (IGF-1) and dehydroepiandrosterone sulfate in obese women. Int J Obesity 1993;17:481-483.
38. Schriock ED, Buffington CK, Hubert GD et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988;66:1329-1331.
39. Nestler, JE, Clore JN, Strauss JF, Blackard WG. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and Acanthosis Nigricans. J Clin Endocrinol Metab 1987;64:180-184.
40. Vogiatzi MG, Boeck MA, Vlachopapadopoulou E et al. Dehydroepiandrosterone in morbidly obese adolescents: Effects on weight, body composition, lipids, and insulin resistance. Metabolism 1996;45:1011-1015.
41. Haffner SM, Valdez RA, Mykkanen L et al. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994;43:599-603.
42. Haffner SM, Newcomb PA, Marcus PM et al. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 1995;142:925-934.
43. Buffington CK, Pourmotabbed G, Kitabchi AE. Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone. Am J Med Sci 1993;306:320-324.
44. Barrett-Connor E, Khaw KT, Yen SSC. Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. N Engl J Med 1987;317:711.
45. Mitchell LE, Sprecher DL, Borecki IB et al. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal premature myocardial infarction in males. Circulation 1994;89:89-93.
46. Herrington DM, Gordon GB, Achuff SC et al. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-870.
47. Zumoff, B, Bradlow HL. Sex difference in the metabolism of dehydroisoandrosterone Sulfate. J Clin Endocrinol Metab 1980;51:334-336.
48. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
49. Zumoff B, Rosenfeld RS, Strain GW et al. Sex Differences in the twentyfour-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1980;51:330-333.
50. Nestler JE, Kahwash Z. Sex specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Invest 1994: 94:1484-1489.
51. Carlstrom K, Brody S, Lunell NO et al. Dehydroepiandrosterone in serum: Differences related to age and sex. Maturitus 1988;10:297-306.
52. Sandberg E, Gurpide E, Lieberman S. Quantitative studies on the metabolism of dehydroepiandrosterone sulfate. Biochemistry 1964;14:1256-1267.
53. Rice T, Sprecher DL, Borecki IB et al. The Cincinnati Miocardial Infarction and Hormone Family Study: Family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families. Metab Clin Exp 1993;42:1284-1290.
54. Beer NA, Jakubowicz DJ, Beer RM, Nestler JE. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum Cortisol, in insulin-resistant obese and hypertensive men. J Clin Endocrin Metab 1993;76:1464-1469.
55. Beer NA, Jakubowicz DJ, Beer RM et al. Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993;76:178-183.